Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Clinical trial NCT04823052 · WITHDRAWN

Trial details

NCT number: NCT04823052
Sponsor: Healx Limited
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2022-05-25
Primary completion: 2022-10-19
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.